Loading clinical trials...
Loading clinical trials...
A Phase II Trial to Evaluate the Safety and Efficacy of Oral Encapsulated Microbiota Transplantation Therapy in Peanut Allergic Patients
Conditions
Interventions
Microbial Transplantation Therapy
Antibiotic
+3 more
Locations
1
United States
Boston Children's Hospital
Boston, Massachusetts, United States
Start Date
June 8, 2023
Primary Completion Date
January 11, 2027
Completion Date
March 1, 2027
Last Updated
August 24, 2025
NCT03835767
NCT04222491
NCT04511494
NCT05424731
NCT03881696
NCT07117669
Lead Sponsor
Rima Rachid
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions